Dr. David Binder, MD, PhD
Claim this profileStudies Pancreatic Cancer
1 reported clinical trial
1 drug studied
More about David Binder, MD, PhD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments David Binder, MD, PhD has experience with
- TTI-101
Breakdown of trials David Binder, MD, PhD has run
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Binder, MD, PhD specialize in?
David Binder, MD, PhD focuses on Pancreatic Cancer and other conditions. In particular, much of their work with Pancreatic Cancer has involved treating patients, or patients who are undergoing treatment.
Is David Binder, MD, PhD currently recruiting for clinical trials?
No, David Binder, MD, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that David Binder, MD, PhD has studied deeply?
Yes, David Binder, MD, PhD has studied treatments such as TTI-101.
What is the best way to schedule an appointment with David Binder, MD, PhD?
Apply for one of the trials that David Binder, MD, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.